To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Rapid decline of JAK2V617… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Rapid decline of JAK2V617F levels during hydroxyurea treatment in patients with polycythemia vera and essential thrombocythemia.

Journal article
Authors Anne Ricksten
Lars Palmqvist
Peter Johansson
Björn Andreasson
Published in Haematologica
Volume 93
Issue 8
Pages 1260-1
ISSN 1592-8721
Publication year 2008
Published at Institute of Biomedicine, Department of Clinical Chemistry and Transfusion Medicine
Institute of Medicine, Department of Internal Medicine
Pages 1260-1
Language en
Links dx.doi.org/10.3324/haematol.12801
Keywords Aged, Aged, 80 and over, Amino Acid Substitution, Antisickling Agents, therapeutic use, Female, Humans, Hydroxyurea, therapeutic use, Janus Kinase 2, genetics, Leukocyte Count, Male, Middle Aged, Polycythemia Vera, blood, drug therapy, genetics, Polymorphism, Single Nucleotide, Thrombocythemia, Essential, blood, drug therapy, genetics
Subject categories Molecular medicine (genetics and pathology), Hematology
Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?